Northern-based drugmaker Galen Holdings has bought an exclusive licence for a generic version of its Ovcon 35 oral contraceptive from Barr Pharmaceuticals.
Sat, 08 May, 2004 - 01:00
In March, Barr granted Galen an option to acquire the exclusive licence for Ovcon 35, which was then pending at the US Food & Drug Administration.